Exelixis Clinical Site #88

Chūōku, Osaka-shi 541-8567

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Prostate Cancer, Prostate Adenocarcinoma

Studies at this site

• Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC — Running, not enrolling